GO:0099625 ventricular cardiac muscle cell membrane repolarization: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0099625 describes the ion transport across the plasma membrane of ventricular cardiac muscle cells that returns the membrane potential from a positive plateau toward the negative resting potential.
• Repolarization is driven by a coordinated balance of outward potassium currents (Ito, IKr, IKs, IK1) and inactivation of inward calcium current, with the Na+/Ca2+ exchanger and other transporters contributing.
• Loss-of-function or gain-of-function changes in repolarizing ion channels cause long QT syndrome, short QT syndrome, Brugada syndrome and other arrhythmia syndromes.
• Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are a validated platform for assessing drug effects on ventricular repolarization and proarrhythmic risk.
• Repolarization reserve is a quantitative concept: multiple redundant outward currents protect the ventricle, so a single channel lesion may remain latent until a second stressor is applied.
• CRISPR knockout, point-mutation knock-in and overexpression models allow causal testing of repolarization genes in isogenic cardiomyocyte backgrounds.
Description
Ventricular cardiac muscle cell membrane repolarization (GO:0099625) is the biological process in which ions are transported across the plasma membrane of a ventricular cardiac muscle cell so that the membrane potential moves in the repolarizing direction, from the positive plateau of the action potential toward the negative resting potential. This process is the electrical signature that terminates the ventricular action potential and resets the cell for the next heartbeat, and its timing is a major determinant of the QT interval on the electrocardiogram. Because repolarization depends on the coordinated activity of multiple ion channels and transporters, even small changes in their expression or gating can produce clinically significant arrhythmia risk.
ventricular cardiac muscle cell membrane repolarization At A Glance
| GO ID | GO:0099625 |
|---|---|
| GO term | ventricular cardiac muscle cell membrane repolarization |
| Ontology | biological_process |
| Synonym | none |
| Major function | Return the ventricular cardiac muscle cell membrane potential from the positive action potential plateau toward the negative resting potential by ion transport across the plasma membrane |
| Cell type | Ventricular cardiac muscle cell (ventricular cardiomyocyte) |
| Direction of potential change | Repolarizing direction, toward the steady state (resting) potential |
| Key currents | Transient outward K+ current (Ito), rapid and slow delayed rectifier K+ currents (IKr, IKs), inward rectifier K+ current (IK1), L-type Ca2+ current inactivation, Na+/Ca2+ exchanger |
| Physiological readout | Action potential duration and QT interval |
What Is GO:0099625?
In the QuickGO definition, GO:0099625 is the process in which ions are transported across the plasma membrane of a ventricular cardiac muscle cell such that the membrane potential changes in the repolarizing direction, toward the steady state potential; for example, the repolarization during an action potential is from a positive membrane potential toward a negative resting potential. In practice, this means the net outward movement of positive charge (mainly K+) and the decline of inward Ca2+ current that together return the ventricular myocyte to its resting electrical state.
Why Is ventricular cardiac muscle cell membrane repolarization Important in Cell Biology?
Repolarization is the gate that controls when a ventricular myocyte can fire again, so its duration and stability directly determine susceptibility to re-entrant arrhythmias and sudden cardiac death. Pharmacological prolongation of repolarization (QT prolongation) is a leading cause of drug withdrawal, making this process a central safety endpoint in cardiac drug development. In addition, inherited channelopathies that alter repolarization are among the best-characterized monogenic causes of arrhythmia, providing a template for precision cardiovascular medicine.
• Sets action potential duration and the QT interval, the primary electrocardiographic index of ventricular repolarization.
• Determines the refractory period and therefore the vulnerability window for re-entrant ventricular arrhythmias.
• Is the mechanistic target of Class III antiarrhythmic drugs and of many non-cardiac drugs that cause QT prolongation.
• Loss-of-function variants in repolarizing K+ channels cause long QT syndrome and increase sudden death risk.
• Gain-of-function or trafficking defects in repolarizing channels contribute to short QT syndrome and Brugada syndrome.
• Repolarization reserve explains why a single channel lesion may be clinically silent until a second hit (drug, hypokalemia, bradycardia) is applied.
• Transient outward K+ current (Ito) remodeling is a recognized contributor to heart failure arrhythmogenesis.
• hiPSC-CM models enable patient-specific and drug-specific assessment of repolarization phenotypes.
• Small-conductance Ca2+-activated K+ channels modulate repolarization and are emerging antiarrhythmic targets.
• Connexin-43 trafficking and gap-junctional coupling influence impulse propagation and the electrical substrate for repolarization-dependent arrhythmias.
What Happens During ventricular cardiac muscle cell membrane repolarization?
Phase 1: Early rapid repolarization (Ito)
In simple terms: The first quick dip in voltage happens because a potassium current briefly turns on and a sodium current turns off.
After the rapid upstroke, the transient outward potassium current (Ito) activates and the fast sodium current inactivates, producing the early notch (phase 1) of the ventricular action potential. Ito density and kinetics vary across the ventricular wall and are remodeled in heart failure, where reduced Ito contributes to action potential prolongation. This early phase sets the initial conditions for the plateau and for the subsequent repolarizing currents.
Phase 2: Plateau and the balance of inward and outward currents
In simple terms: During the plateau, calcium keeps flowing in while potassium starts to leak out, so the voltage stays high for a while.
The plateau is maintained by a fine balance between inward L-type Ca2+ current and outward K+ currents, including the slow and rapid delayed rectifiers IKs and IKr. Because these currents overlap in time, small changes in any one of them can shift the plateau duration; this redundancy is the basis of the repolarization reserve concept. In silico current-voltage-time analysis shows that the plateau is a region of high membrane resistance where small current changes produce large duration changes.
Phase 3: Rapid repolarization (IKr, IKs, IK1)
In simple terms: Potassium channels open wide and calcium channels close, so the voltage falls quickly back to rest.
As L-type Ca2+ channels inactivate and IKr and IKs remain active, the net outward current drives phase 3 repolarization. The inward rectifier IK1 then dominates near the resting potential, stabilizing the diastolic membrane voltage. Pharmacological block of IKr (for example by dofetilide or cisapride) prolongs phase 3 and is the classic mechanism of drug-induced QT prolongation.
Phase 4: Restoration of the resting potential and ion homeostasis
In simple terms: After the voltage returns to rest, pumps and exchangers restore the ion gradients for the next beat.
Repolarization is completed when the membrane potential returns to the negative diastolic value maintained largely by IK1. The Na+/K+-ATPase and Na+/Ca2+ exchanger restore ionic gradients, and the Na+/Ca2+ exchanger can also carry a depolarizing or repolarizing current depending on conditions. Failure to restore homeostasis, as in ischemia or heart failure, alters subsequent action potentials and promotes arrhythmia.
Modulation by accessory proteins and non-canonical currents
In simple terms: Other proteins can tune repolarization without being the main channels themselves.
Accessory subunits and interacting proteins modulate the trafficking and gating of repolarizing channels; for example, FGF13 regulates cardiomyocyte impulse propagation via connexin-43 trafficking, linking non-channel proteins to the electrical substrate. Small-conductance Ca2+-activated K+ channels can also contribute to repolarization and have been pharmacologically enhanced to suppress arrhythmias in a mouse model of catecholaminergic polymorphic ventricular tachycardia. These findings broaden the set of genes that can be tested for causal roles in GO:0099625.
Key Genes Involved in GO:0099625 ventricular cardiac muscle cell membrane repolarization
The following genes encode channels, transporters and accessory proteins that directly or indirectly shape ventricular cardiac muscle cell membrane repolarization (GO:0099625).
| Gene | Major Role | Research Relevance |
|---|---|---|
| KCNH2 (hERG) | Pore-forming alpha subunit of the rapid delayed rectifier K+ current IKr | Primary target of drug-induced QT prolongation and long QT syndrome type 2 |
| KCNQ1 | Pore-forming alpha subunit of the slow delayed rectifier K+ current IKs | Long QT syndrome type 1 and repolarization reserve |
| KCNE1 | Beta subunit that modulates IKs gating and amplitude | Modifier of IKs-dependent repolarization and arrhythmia risk |
| KCNE2 | Beta subunit that can modulate IKr and other K+ currents | Modifier of drug sensitivity and repolarization |
| KCND3 | Pore-forming alpha subunit of the transient outward current Ito | Early repolarization and heart failure remodeling |
| KCNIP2 | Beta subunit that modulates Ito gating and trafficking | Ito regulation and ventricular repolarization heterogeneity |
| KCNJ2 | Pore-forming alpha subunit of the inward rectifier IK1 | Resting potential stabilization and Andersen-Tawil syndrome |
| KCNJ12 | Inward rectifier K+ channel contributing to IK1 in some species | IK1-dependent repolarization and excitability |
| CACNA1C | Pore-forming alpha subunit of the L-type Ca2+ channel | Plateau maintenance and Timothy syndrome / Brugada overlap |
| SCN5A | Pore-forming alpha subunit of the cardiac Na+ channel | Upstroke and late Na+ current that influences repolarization |
| SCN1B | Beta subunit of the cardiac Na+ channel | Modulation of Na+ current and repolarization |
| SLC8A1 (NCX1) | Na+/Ca2+ exchanger that can carry repolarizing or depolarizing current | Calcium handling and action potential duration |
| ATP1A1 | Na+/K+-ATPase alpha subunit that restores ion gradients | Ion homeostasis and repolarization recovery |
| FGF13 | Fibroblast growth factor homologous factor regulating Cx43 trafficking | Non-canonical regulation of impulse propagation and electrical coupling |
| GJA1 (Cx43) | Gap junction protein mediating cell-to-cell electrical coupling | Impulse propagation and arrhythmia substrate |
| KCNN2 | Small-conductance Ca2+-activated K+ channel contributing to repolarization | Emerging antiarrhythmic target in CPVT models |
| KCNN3 | Small-conductance Ca2+-activated K+ channel modulating repolarization | Repolarization modulation and atrial/ventricular arrhythmia |
| CALM1 | Calmodulin, calcium sensor regulating multiple ion channels | Calmodulinopathy and repolarization instability |
How Is ventricular cardiac muscle cell membrane repolarization Regulated?
Repolarization is regulated at multiple levels. Acute regulation occurs through voltage-dependent gating, beta-adrenergic phosphorylation of IKs and L-type Ca2+ channels, and calcium-calmodulin-dependent modulation of channel activity. Transcriptional and trafficking regulation controls channel abundance at the membrane; for example, FGF13 influences connexin-43 trafficking and thereby the electrical coupling that shapes impulse propagation and repolarization-dependent arrhythmia substrates. Pharmacological regulation by Class III antiarrhythmics and by non-cardiac drugs that block IKr directly alters repolarization time course. Finally, repolarization reserve is an emergent regulatory property: because multiple outward currents overlap, compensatory changes in one current can mask or unmask the effect of another.
ventricular cardiac muscle cell membrane repolarization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNH2 | Long QT syndrome type 2 and drug-induced QT prolongation | hiPSC-CM knockout or point-mutation knock-in of KCNH2 with action potential duration readout |
| KCNQ1 | Long QT syndrome type 1 and repolarization reserve | Isogenic KCNQ1 knockout and missense knock-in cardiomyocytes |
| SCN5A | Long QT syndrome type 3 and Brugada syndrome | SCN5A point-mutation knock-in hiPSC-CMs with late Na+ current measurement |
| KCND3 / KCNIP2 | Ito remodeling in heart failure and early repolarization | Overexpression or knockout in cardiomyocytes with patch-clamp Ito recording |
| KCNN2 / KCNN3 | CPVT arrhythmia suppression by SK channel enhancement | Mouse CPVT model with pharmacological SK channel enhancement and arrhythmia monitoring |
Long QT syndrome and inherited channelopathies
Long QT syndrome is the archetypal disorder of ventricular repolarization. Loss-of-function variants in KCNQ1 (LQT1), KCNH2 (LQT2) and SCN5A (LQT3) prolong the action potential and increase the risk of torsades de pointes and sudden cardiac death. The genetics of LQT syndrome have been reviewed in detail, and genotype-specific management is now part of clinical practice. Because these variants act by altering repolarizing currents, they map directly onto GO:0099625.
Drug-induced QT prolongation and proarrhythmia
Many drugs, including some antihistamines, antibiotics and antipsychotics, block IKr and prolong ventricular repolarization, creating a risk of torsades de pointes. The International Multisite Study of hiPSC-CMs demonstrated that human induced pluripotent stem cell-derived cardiomyocytes can detect drug-induced proarrhythmic potential across multiple sites, supporting their use as a preclinical repolarization assay. This makes GO:0099625 a direct safety pharmacology endpoint.
Heart failure and electrical remodeling
In heart failure, reduced transient outward potassium current (Ito) and altered calcium handling prolong action potential duration and destabilize repolarization, contributing to arrhythmia and sudden death. These changes are part of a broader electrical remodeling process that includes altered channel expression and gap-junction redistribution. Targeting repolarization reserve in this setting is an active area of translational research.
Catecholaminergic polymorphic ventricular tachycardia and calcium-dependent repolarization instability
In catecholaminergic polymorphic ventricular tachycardia (CPVT), adrenergic stress triggers calcium-dependent arrhythmias, and pharmacological enhancement of small-conductance Ca2+-activated K+ channels suppresses these arrhythmias in a mouse model. This links calcium signaling to repolarizing currents and shows that modulating repolarization can be antiarrhythmic rather than merely proarrhythmic. The finding expands the therapeutic hypothesis space around GO:0099625.
From ventricular cardiac muscle cell membrane repolarization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for normal ventricular repolarization? | CRISPR knockout in hiPSC-CMs or in a ventricular myocyte line, with action potential duration and ion current readout |
| Does a patient variant alter repolarization? | Isogenic point-mutation knock-in of the variant in hiPSC-CMs |
| Does a repolarizing channel need a specific subunit for trafficking? | Tagged knock-in of the channel or subunit with imaging and biochemical trafficking assays |
| Does overexpression of a modifier gene change repolarization reserve? | Doxycycline-inducible overexpression in cardiomyocytes with patch-clamp and calcium imaging |
| Which genes modify drug-induced QT prolongation? | CRISPR library screening in hiPSC-CMs followed by action potential or viability selection |
| Does a non-channel gene affect impulse propagation and repolarization substrate? | Knockout or knockdown of the gene with connexin-43 imaging and optical mapping |
How to Study the ventricular cardiac muscle cell membrane repolarization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Ion currents and action potential duration | Assigning a gene to a repolarization phase |
| Optical mapping | Spatial action potential duration and repolarization dispersion | Arrhythmia substrate assessment |
| hiPSC-CM multiwell assay | Drug-induced repolarization changes and proarrhythmic risk | Preclinical safety pharmacology |
| In silico action potential modeling | Repolarization reserve and current-voltage-time relationships | Hypothesis generation and data interpretation |
| Calcium imaging | Intracellular calcium transients and arrhythmogenic calcium release | CPVT and calcium-dependent arrhythmia studies |
| ECG / telemetry | QT interval and arrhythmia incidence in vivo | Animal model phenotyping |
| Western blot and imaging | Channel and connexin protein levels and localization | Trafficking and remodeling studies |
| CRISPR library screening | Gene requirements for repolarization or drug response | Discovery of modifiers of repolarization |
Patch-clamp electrophysiology
Patch-clamp recording in voltage-clamp or current-clamp mode measures individual repolarizing currents and action potential duration directly, and it has been central to understanding the ventricular action potential since the single-cell voltage-clamp era. It remains the gold-standard method for assigning a current to a specific phase of repolarization.
Optical mapping and voltage-sensitive dyes
Optical mapping with voltage-sensitive dyes records action potential duration and repolarization heterogeneity across multicellular preparations or hiPSC-CM monolayers. This approach captures spatial dispersion of repolarization, a key substrate for re-entry.
hiPSC-CM drug response assays
Human induced pluripotent stem cell-derived cardiomyocytes can be used in multiwell platforms to assess drug effects on repolarization and proarrhythmic potential, as shown in an international multisite validation study. These assays are now widely used in preclinical safety pharmacology.
In silico action potential modeling
Computational models of the ventricular action potential allow current-voltage-time analysis and quantification of repolarization reserve, thresholds and membrane resistance. Such models help interpret experimental data and predict the consequences of channel perturbations.
Calcium imaging and arrhythmia monitoring
Calcium imaging and telemetry or ECG monitoring in animal models link cellular repolarization changes to triggered activity and arrhythmia in vivo, as demonstrated in CPVT studies with SK channel enhancement. These methods connect molecular mechanisms to organism-level phenotypes.
How CRISPR Can Be Used to Study GO:0099625 ventricular cardiac muscle cell membrane repolarization
Knockout
CRISPR knockout of a candidate repolarization gene in hiPSC-CMs or a cardiomyocyte line can test whether the gene is required for normal action potential duration and ion current density. Isogenic knockout lines reduce background variability and allow direct comparison with wild-type cells.
Point Mutation
Point-mutation knock-in of a patient variant, such as a KCNH2 or SCN5A missense change, creates an isogenic model to test whether the variant alters repolarization and drug sensitivity. This approach is particularly valuable for variants of uncertain significance in long QT syndrome genes.
Knock-in
Tagged knock-in of a channel or accessory protein allows tracking of its trafficking and localization, which is important because repolarization depends on channels reaching the membrane. For example, tagging approaches can reveal how FGF13 influences connexin-43 trafficking and electrical coupling.
Overexpression
Overexpression of a modifier gene or a repolarizing channel can test gain-of-function effects on repolarization reserve and arrhythmia susceptibility. Inducible overexpression systems allow dose- and time-controlled experiments in cardiomyocytes.
How EDITGENE Supports ventricular cardiac muscle cell membrane repolarization Research
Researchers studying ventricular cardiac muscle cell membrane repolarization-related genes often need to determine whether a candidate gene is causally involved in setting action potential duration, whether a patient variant changes repolarization, or whether a modifier gene alters repolarization reserve. Answering these questions requires isogenic, well-controlled cell models that combine precise genetic editing with electrophysiological and imaging readouts.
Contact EDITGENE today to design your custom CRISPR model for ventricular cardiac muscle cell membrane repolarization research.
Frequently Asked Questions About ventricular cardiac muscle cell membrane repolarization
What is GO:0099625 ventricular cardiac muscle cell membrane repolarization?
GO:0099625 is the biological process in which ions are transported across the plasma membrane of a ventricular cardiac muscle cell so that the membrane potential changes in the repolarizing direction, toward the steady state potential, for example from the positive action potential plateau toward the negative resting potential.
What genes are involved in ventricular cardiac muscle cell membrane repolarization?
Key genes include KCNH2, KCNQ1, KCNE1, KCNE2, KCND3, KCNIP2, KCNJ2, CACNA1C, SCN5A, SLC8A1, ATP1A1, GJA1, FGF13, KCNN2 and KCNN3, which encode repolarizing channels, transporters and accessory proteins.
Why is ventricular repolarization important for drug safety?
Many drugs block IKr and prolong repolarization, which can cause torsades de pointes; hiPSC-CM assays can detect this proarrhythmic potential in preclinical testing.
What is repolarization reserve?
Repolarization reserve is the redundancy provided by multiple overlapping outward currents, so that a single channel lesion may not prolong the action potential until a second stressor is applied.
Which diseases are linked to abnormal ventricular repolarization?
Long QT syndrome, short QT syndrome, Brugada syndrome, drug-induced QT prolongation and heart failure-related arrhythmias are linked to abnormal ventricular repolarization.
How do you measure ventricular cardiac muscle cell membrane repolarization?
Patch-clamp electrophysiology, optical mapping, hiPSC-CM multiwell assays, ECG telemetry and in silico action potential modeling are commonly used to measure repolarization.
Can CRISPR be used to study repolarization genes?
Yes; CRISPR knockout, point-mutation knock-in, tagged knock-in and overexpression in cardiomyocyte models allow causal testing of repolarization genes and patient variants.
What is the role of Ito in repolarization?
The transient outward potassium current Ito contributes to early repolarization (phase 1) and is remodeled in heart failure, where reduced Ito prolongs the action potential.
How does FGF13 relate to cardiac repolarization?
FGF13 regulates cardiomyocyte impulse propagation via connexin-43 trafficking, linking a non-channel protein to the electrical substrate that shapes repolarization-dependent arrhythmias.
Are small-conductance Ca2+-activated K+ channels involved in repolarization?
Yes; pharmacological enhancement of small-conductance Ca2+-activated K+ channels suppresses cardiac arrhythmias in a mouse model of catecholaminergic polymorphic ventricular tachycardia, indicating a modulatory role in repolarization.
Conclusion
GO:0099625 ventricular cardiac muscle cell membrane repolarization is a tightly regulated, multi-current process that determines action potential duration, QT interval and arrhythmia susceptibility. Its clinical importance spans inherited channelopathies, drug-induced proarrhythmia and heart failure-related electrical remodeling. Isogenic CRISPR models combined with electrophysiology, imaging and in silico analysis provide a rigorous path to assign causal roles to repolarization genes and to test therapeutic hypotheses.
References
- 1. Blinova K et al.. 2018. International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment.. Cell Rep 24(13):3582-3592 PMID: 30257217
- 2. Das LT et al.. 2025. FGF13 Regulates VGSC-Independent Cardiomyocyte Impulse Propagation via Cx43 Trafficking.. Circ Res 137(12):1522-1539 PMID: 41200819
- 3. Osadchii OE. 2017. Role of abnormal repolarization in the mechanism of cardiac arrhythmia.. Acta Physiol (Oxf) 220 Suppl 712:1-71 PMID: 28707396
- 4. Zaniboni M. 2024. In silico analysis of ventricular action potential with a current-voltage-time representation: Thresholds, membrane resistance, repolarization reserve.. Physiol Rep 12(21):e70085 PMID: 39529595
- 5. Wallace E et al.. 2019. Long QT Syndrome: Genetics and Future Perspective.. Pediatr Cardiol 40(7):1419-1430 PMID: 31440766
- 6. He Q et al.. 2015. Transient outward potassium channel: a heart failure mediator.. Heart Fail Rev 20(3):349-62 PMID: 25646587
- 7. Varró A et al.. 1992. The impact of single cell voltage clamp on the understanding of the cardiac ventricular action potential.. Cardioscience 3(3):131-44 PMID: 1384746
- 8. Veress R et al.. 2025. Pharmacological Enhancement of Small Conductance Ca(2+)-Activated K(+) Channels Suppresses Cardiac Arrhythmias in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia.. Circ Res 137(3):386-399 PMID: 40438932
